Claudio Isella
Candiolo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Tyrosine kinase inhibitors in Kosaki/Penttinen syndromes: new reports, follow-up of treated individuals and literature review.
Journal: European journal of human genetics : EJHG
Published: September 05, 2025
Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: May 15, 2025
Concurrent RB1 and P53 pathway disruption predisposes to the development of a primitive neuronal component in high-grade gliomas depending on MYC-driven EBF3 transcription.
Journal: Acta neuropathologica
Published: October 21, 2024
Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Journal: Nature genetics
Published: June 03, 2024
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 30, 2023
Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer patient-derived xenografts.
Journal: Nature communications
Published: January 10, 2023
Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.
Journal: Nature genetics
Published: December 04, 2022
Coexisting cancer stem cells with heterogeneous gene amplifications, transcriptional profiles, and malignancy are isolated from single glioblastomas.
Journal: Cell reports
Published: September 16, 2022
The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway.
Journal: Journal of experimental & clinical cancer research : CR
Published: May 09, 2022
DNA damage response and repair genes in advanced bone and soft tissue sarcomas: An 8-gene signature as a candidate predictive biomarker of response to trabectedin and olaparib combination.
Journal: Frontiers in oncology
Published: December 27, 2021
Last Updated: 09/26/2026